¼¿ï¼º¸ðº´¿ø Á¦ 9Â÷ ´ëÇÑÇ÷¾×ÇÐȸ Ç÷¿ìº´¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2020-02-01±³À°ÀÏÀÚ : 2020-02-01
±³À°Àå¼Ò : ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇבּ¸¿ø ´ë°´ç
±³À°ÁÖÁ¦ :
Á¦ 9Â÷ ´ëÇÑÇ÷¾×ÇÐȸ Ç÷¿ìº´¿¬±¸È¸ ½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581
À̸ÞÀÏ :
hematology@kams.or.kr ±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, ¼ºÇü¿Ü°ú
Âü¼®¿¹»óÀοø : 80¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 3 ½Ã°£ 15ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 02-01 ´ë°´ç 13:30~14:00 Emicizumab-Hemlibra ÇÑÁ¤¿ì(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 02-01 ´ë°´ç 14:00~14:30 Non-Factor approach –Fitusiran, anti-TFPI including concizumab ¹Ú¿µ½Ç(°æÈñÀÇ´ë)
±³À°½Ã°£ 02-01 ´ë°´ç 14:40~15:10 Orthopedic surgery for hemophilia (joint replacement) ÀÌÀçÈÆ(°æÈñÀÇ´ë)
±³À°½Ã°£ 02-01 ´ë°´ç 15:10~15:40 Detal management in hemophilia Á¤º¹¿µ(¿¬¼¼Ä¡´ë)
±³À°½Ã°£ 02-01 ´ë°´ç 15:40~16:10 Current Trends in Rehabilitation after joint replacement surgery in hemophilia ±Ç¼¼Áø(Çѱ¹Ç÷¿ìÀç´ÜÀÇ¿ø)
±³À°½Ã°£ 02-01 ´ë°´ç 16:10~16:30 Hemostatic support for the management in the multidisciplinary clinics ¹éÈñÁ¶(°æÈñÀÇ´ë)
±³À°½Ã°£ 02-01 ´ë°´ç 16:50~17:15 Case1 : Factor VII deficiency ÃÖ¿µ¹è(ÃæºÏÀÇ´ë)
±³À°½Ã°£ 02-01 ´ë°´ç 17:15~16:40 Case2 : Glanzmann¡¯s thrombasthenia °Çö½Ä(Á¦ÁÖÀÇ´ë)